University of Illinois at Chicago cancer researchers will have the opportunity to submit proposals for two new grants. The UI Cancer Center will manage the letters of intent, and since both are limited competitions, only one applicant for each sponsor will be selected. The researcher will then be notified he/she can move forward and submit his/her proposal to the foundation.
The first is from the Mary Kay Foundation, a non-profit public foundation which focuses on funding research for innovative grants for translational research in ovarian, uterine, breast or cervical cancer. Translational research is broadly defined as research that will provide a scientific link between laboratory research and the clinic. Ultimately, such research would lead to improvement in diagnosis, prognosis, prevention or treatment of the cancer.
Deadline to submit the letter of intent is Jan. 4, with notification to the principal investigator Jan. 8. Submit LOI here: https://cancer.uillinois.edu/research/letter-of-intent-to-apply-loi/
The grant will be up to $100,000 (combined direct and indirect costs) for a two-year period. The application to the Mary Kay Foundation must be completed no later than 5 p.m., CST, Friday, Feb. 8, 2019.
The second opportunity is from the Damon Runyon Cancer Research Foundation. The Damon Runyon Clinical Investigator Award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine. Learn more about the Damon Runyon Foundation here: https://www.damonrunyon.org/for-scientists/application-guidelines/clinical-investigator
The $600,000 award will be for three years. Funding in the amount of $200,000 will be allocated to the awardee’s institution each year for the support of the Clinical Investigator. Funds are intended to be flexible and can be used for a variety of scientific needs, including the investigator’s stipend and/or fringe benefits (up to $100,000), salaries for professional and technical personnel, special equipment, supplies and other miscellaneous items required to conduct the proposed research. No part of the grant can be used for indirect costs or institutional overhead.
As with the Mary Kay Foundation grant, submission of a letter of intent is due Jan. 4, with a response to the researcher coming on Jan. 8. Submit LOI here: https://cancer.uillinois.edu/research/letter-of-intent-to-apply-loi/
The deadline to submit an application to the foundation is Feb. 1. Learn more about the Damon Runyan opportunity here: https://www.damonrunyon.org/for-scientists/application-guidelines/clinical-investigator